MRK
Merck & Co., Inc. · Healthcare
EVP and CHRO Steven Mizell sold $6.4M of Merck & Co., Inc.
Sold$6,420,349
$126.65Price
50,694Shares
−68%Stake
What MRK did after the filing
- The stock from Mon, Feb 5 open, $126.98
- −3.8%
- S&P 500, same days
- +4.8%
Measured over 30 trading days, to the Mar 19 close.
Traded Fri, Feb 2. Filed Fri, Feb 2, 4:07 PM ET, after the close. Returns use the Feb 5 open and the Mar 19 close. Not investment advice.